Australia
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.12
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 3.04
|
June 30, 2024 | USD 195.76 | 0.28% |
|
Australia |
|
3 |
USD 0.69
|
June 30, 2024 | USD 17.72 | 0.58% |
|
Australia |
|
4 |
USD 0.51
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
5 |
USD 0.41
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
6 |
USD 0.18
|
June 30, 2024 | USD 0.87 | -0.82% |
|
Australia |
|
7 |
USD 0.12
|
June 30, 2024 | USD 1.90 | 0.29% |
|
Australia |
|
8 |
USD 0.05
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
9 |
USD 0.03
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
10 |
USD 0.03
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
11 |
USD 0.00
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
12 |
USD -0.00
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
13 |
USD -0.01
|
June 30, 2024 | USD 0.75 | 1.47% |
|
Australia |
|
14 |
USD -0.02
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
15 |
USD -0.02
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
16 |
USD -0.05
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
17 |
USD -0.06
|
Dec. 31, 2023 | USD 1.45 | -3.95% |
|
Australia |
|
18 |
USD -0.11
|
June 30, 2024 | USD 2.46 | 10.79% |
|
Australia |
|
19 |
USD -0.25
|
June 30, 2024 | NA |
|
Australia |
||
20 |
USD -0.30
|
June 30, 2024 | USD 2.89 | 2.85% |
|
Australia |
|
21 |
USD -1.00
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
22 |
USD -2.40
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
23 |
USD -2.66
|
June 30, 2024 | USD 1.58 | -16.84% |
|
Australia |
The Biotechnology company in Australia with the highest Free Cash Flow Per Share is CSL Limited (ASX: CSL.AX) at USD 3.12.
The Biotechnology company in Australia with the lowest Free Cash Flow Per Share is Kazia Therapeutics Limited (NasdaqCM: KZIA) at USD -2.66.
The top 10 Biotechnology companies in Australia by Free Cash Flow Per Share are CSL Limited, Cochlear Limited, Sonic Healthcare Limited, Australian Clinical Labs Limited, Clinuvel Pharmaceuticals Limited, Healius Limited, Integral Diagnostics Limited, Monash IVF Group Limited, Telix Pharmaceuticals Limited and Cogstate Limited.
The bottom 10 Biotechnology companies in Australia by Free Cash Flow Per Share are Kazia Therapeutics Limited, Anteris Technologies Ltd, Incannex Healthcare Limited, Mayne Pharma Group Limited, Opthea Limited, Clarity Pharmaceuticals Ltd, Cyclopharm Limited, Mesoblast Limited, Immutep Limited and Immuron Limited.